Biodistribution of Therapeutic Extracellular Vesicles
Author Information
Author(s): Gupta Dhanu, Wiklander Oscar P.B, Wood Matthew J.A, El-Andaloussi Samir
Primary Institution: University of Oxford, Karolinska Institutet
Conclusion
Extracellular vesicles (EVs) show a rapid biodistribution primarily to the liver and spleen, which limits their delivery to target tissues.
Supporting Evidence
- Extracellular vesicles are increasingly recognized as important for drug delivery.
- EVs can cross biological barriers and reach difficult-to-target organs.
- Technological advancements have improved the understanding of EV biodistribution.
Takeaway
Scientists are studying tiny bubbles called extracellular vesicles that can carry medicine to specific parts of the body, but they often get stuck in the liver and spleen instead of reaching their target.
Methodology
This review summarizes recent findings in EV pharmacokinetics and discusses biological barriers to tissue-specific delivery.
Limitations
The review highlights the challenges in achieving reliable detection and understanding the pharmacokinetic properties of EVs.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website